PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 19.11.2019 at 4:00 PM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (CA2667445) HIV-1 PROTEASE INHIBITORS

Office : Canada
Application Number: 2667445 Application Date: 21.06.2006
Publication Number: 2667445 Publication Date: 04.01.2007
Publication Kind : A1
Prior PCT appl.: Application Number:US2006024108 ; Publication Number: Click to see the data
IPC:
C07C 311/15
A61K 31/18
A61K 31/34
A61K 31/42
A61K 31/426
A61P 31/18
C07C 311/22
C07D 213/02
C07D 261/06
C07D 277/08
C07D 307/02
C07D 333/04
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
311
Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
15
Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
16
Amides, e.g. hydroxamic acids
18
Sulfonamides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
34
having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
42
Oxazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
425
Thiazoles
426
1,3-Thiazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12
Antivirals
14
for RNA viruses
18
for HIV
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
311
Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
22
Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
213
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
02
having three double bonds between ring members or between ring members and non-ring members
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
261
Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
02
not condensed with other rings
06
having two or more double bonds between ring members or between ring members and non-ring members
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
277
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
02
not condensed with other rings
08
having one double bond between ring members or between a ring member and a non-ring member
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
307
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
02
not condensed with other rings
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
333
Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
02
not condensed with other rings
04
not substituted on the ring sulfur atom
CPC:
C07C 311/05
C07C 233/36
C07C 235/20
C07C 235/50
C07C 237/22
C07C 311/29
C07C 2601/02
C07C 2601/10
C07C 2601/14
C07D 213/81
C07D 215/50
C07D 233/82
C07D 263/20
C07D 277/36
C07D 277/62
C07D 307/64
C07D 309/08
C07D 333/20
C07D 401/12
C07D 401/14
C07D 403/12
C07D 405/12
C07D 405/14
C07D 409/12
C07D 413/12
C07D 413/14
C07D 417/12
Applicants: UNIVERSITY OF MASSACHUSETTS
THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY
UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
Inventors: SCHIFFER, CELIA A.
RANA, TARIQ M.
GILSON, MICHAEL
TIDOR, BRUCE
KAIRYS, VISVALDAS
KING, NANCY
NALAM, MADHAVI NAGGA LAXMI
NALIVAIKA, ELLEN
PRABU, MOSES
ALI, AKBAR
CAO, HONG
GARUDAMMAGARI SAI, KIRAN KUMAR REDDY
ANJUM, SAIMA GHAFOOR
ALTMAN, MICHAEL D.
CHELLAPPAN, SRIPRIYA
FERNANDES, MIGUEL X
Priority Data: 60/693,134 22.06.2005 US
Title: (EN) HIV-1 PROTEASE INHIBITORS
(FR) INHIBITEURS DE LA PROTEASE DU VIH-1
Abstract:
(EN) Described are novel protease inhibitors and methods for using said protease inhibitors in the treatment of human immunodeficiency virus (HIV) infection.


Also published as:
EP1937631JP2008546789CN101296901AU2006262274WO/2007/002172